USFDA approves label update for Rybelsus allowing use as first-line option for adults with type 2 diabetes: Novo Nordisk Ruchika Sharma16 Jan 2023 4:15 PM ISTPlainsboro: Novo Nordisk has announced that the U.S. Food and Drug Administration (FDA) has approved a label update for Rybelsus (semaglutide) tablets...
FDA approves injectable semaglutide for people with obesity ages 12 and more Dr. Kamal Kant Kohli1 Jan 2023 8:00 PM ISTThe U.S. Food and Drug Administration (FDA) has approved a new indication for Wegovy (semaglutide) injection 2.4 mg, making it the first-and-only...
Subcutaneous semaglutide beneficial in weight loss management says JAMA Jacinthlyn Sylvia7 Dec 2022 10:45 AM ISTUSA: Weekly semaglutide dosages of 1.7 mg and 2.4 mg were linked to weight reduction says a study published in the Journal of American Medical...
Semaglutide significantly effective for weight loss in teenagers too: NEJM Study Medha Baranwal4 Nov 2022 11:30 AM ISTAustria: Semaglutide is an obesity drug that mimics a hormone called glucagon-like peptide-1 to target areas of the brain that decrease appetite and...
SC semaglutide, if given continuously for two years, maintains weight loss in obese adults: STEP 5 trial Medha Baranwal20 Oct 2022 8:00 PM ISTUSA: Findings from the STEP 5 trial showed that weekly semaglutide 2.4 mg treatment led to substantial, sustained weight loss for two years in...
Submit safety data of initial 30 subjects : CDSCO Tells Novo-Nordisk On IcoSema and insulin icodec study Dr. Divya Colin28 Sept 2022 6:00 PM ISTNew Delhi: Citing to remove the 'interim analysis' from the said condition, the Subject Expert Committee (SEC) functional under Central Drug Standard...
EASD Highlights Isra Zaman24 Sept 2022 9:45 AM ISTType 2 diabetes worst affects life expectancy of women, younger people and smokers: ResearchNew research presented at the annual meeting of the...
EASD Highlights Isra Zaman21 Sept 2022 11:15 AM ISTDairy products in moderate amounts may protect against type 2 diabetes-but red and processed meat raise risk.Dairy products, especially low-fat ones...
NovoNordisk Gets CDSCO Panel Nod To Study anti-diabetic FDC Cagrilinitide,Semaglutide Dr. Divya Colin19 Sept 2022 6:00 PM ISTNew Delhi: Advising to submit the trial safety and efficacy data, the Subject Expert Committee (SEC) of the Central Drugs Standard Control...
Semaglutide reduces diabetes risk by 61% in individuals with prediabetes or normal blood sugar levels Dr. Kamal Kant Kohli12 Sept 2022 11:29 AM ISTSemaglutide has recently been approved in US as an obesity treatment and has been provisionally approved to treat obesity in England. According to a...
Semaglutide, optimal therapy for type 2 diabetes with few side effects: Study Medha Baranwal2 Jun 2022 10:45 AM ISTEgypt: Tirzepatide, oral, and subcutaneous (SC) semaglutide have a favorable efficacy for type 2 diabetes treatment, according to results from a...
Oral semaglutide greatly reduces blood sugar and weight in type 2 diabetes patients: Study Medha Baranwal23 April 2022 9:15 AM ISTUSA: Treatment with oral semaglutide in type 2 diabetes patients results in consistently greater HbA1c reduction and weight loss, and more...
